CAPR · Capricor Therapeutics, Inc.
Market Cap
$557.55M
Shares
58.14M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-19 | Musket David B | Director | 88,788 | 2026-05-19 | Fidelity Brokerage Services LLC |
| 2026-04-02 | Karimah Es Sabar | Director | 7,529 | 2026-04-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-31 | Karen Krasney | Officer | 75,000 | 2026-03-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-31 | ANTHONY BERGMANN | Officer | 75,000 | 2026-03-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-31 | Karimah Es Sabar | Director | 115,000 | 2026-03-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings
Key facts
CIK
1133869
CUSIP
14070B309
13F (30d)
163 filings
159 filers
Visit website
Investor relations